167 filings
Page 3 of 9
8-K
9lwjwp53s0m0io295bph
29 Jun 20
Submission of Matters to a Vote of Security Holders
1:14pm
DEFA14A
q7se4x1ijv0upysc
29 Apr 20
Additional proxy soliciting materials
3:27pm
SC TO-I/A
3mmh2o4mtpb q9go
19 Feb 20
Issuer tender offer statement (amended)
8:22am
SC TO-I/A
n1op1zj82mgvtnr2i
13 Feb 20
Issuer tender offer statement (amended)
2:24pm
SC TO-I/A
09kt5
13 Feb 20
Issuer tender offer statement (amended)
8:21am
SC TO-I/A
d5e7 7n3roq1klc8xh57
5 Feb 20
Issuer tender offer statement (amended)
4:44pm
SC TO-I
8tvxfqtw
14 Jan 20
Issuer tender offer statement
8:39am
8-K
x17n6tv f5vk8
30 Dec 19
XBiotech Closes on Sale of True Human Antibody Bermekimab to Janssen
5:08pm
8-K
l7bxcp8
9 Dec 19
XBiotech Announces Agreement to Sell True Human Antibody Bermekimab Targeting IL-1a to Janssen
4:28pm
8-K
flvy3c l72o3e93jo
16 Jul 19
XBiotech Adds Dr. Peter Libby, Renowned Cardiologist and Research Pioneer in Inflammation and Cardiovascular Disease, to its Corporate Board
12:36pm
8-K
yqpdp879rf0fp6
20 Jun 19
Submission of Matters to a Vote of Security Holders
1:16pm
8-K
nz4kih 2g
3 Jun 19
XBiotech Announces Pricing of Public Offering of Common Shares
4:48pm
424B5
am2mkw5wx0cstvcz
3 Jun 19
Prospectus supplement for primary offering
4:46pm
S-3MEF
x9iq3
31 May 19
Registration of additional securities for an S-3
8:51am
424B5
ii6vbwpyplwul3hw
31 May 19
Prospectus supplement for primary offering
12:00am